Wird geladen...

Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol

INTRODUCTION: Pre-eclampsia is a common pregnancy condition affecting between 3% and 7% of women. Unfortunately, the exact pathophysiology of the disease is unknown and as such there are no effective treatments that exist notwithstanding prompt delivery of the fetus and culprit placenta. As many cas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hobson, Sebastian R, Lim, Rebecca, Gardiner, Elizabeth E, Alers, Nicole O, Wallace, Euan M
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3780337/
https://ncbi.nlm.nih.gov/pubmed/24056493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003788
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!